Welcome to our dedicated page for North Amern Cannabis Hldgs news (Ticker: USMJ), a resource for investors and traders seeking the latest updates and insights on North Amern Cannabis Hldgs stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect North Amern Cannabis Hldgs's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of North Amern Cannabis Hldgs's position in the market.
USMJ.com, a subsidiary of North American Cannabis Holdings, has announced a partnership with Wasatch Hemp Farm from Utah. This collaboration introduces four new products, including creams and gel capsules that contain 1500mg of CBD, with the pain cream also featuring an additional 750mg of CBG. USMJ aims to strengthen its presence in the expanding cannabis market by partnering with American companies. CEO Steven Rash emphasized the importance of supporting local businesses as part of their growth strategy.